SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-060261
Filing Date
2019-11-06
Accepted
2019-11-06 07:10:24
Documents
3
Period of Report
2019-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm1921779d1_6k.htm 6-K 228197
2 EXHIBIT 99.1 tm1921779d1_ex99-1.htm EX-99.1 94378
3 GRAPHIC tm1921779d1_img001.jpg GRAPHIC 12508
  Complete submission text file 0001104659-19-060261.txt   340954
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 191195050
SIC: 2834 Pharmaceutical Preparations